Automatically mailing a stool test kit to people's homes might be the best way to boost colon cancer screening among younger adults, a new study says. More 45- to 49-year-olds went ahead with cancer ...

The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s RNA-based colorectal cancer (CRC) screening test, ColoSense. The new kit enhances user ...

ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that the U.S. Food and Drug ...

Colonoscopy remains the gold-standard means of colon cancer screening, as the procedure can prevent cancers by removing ...

SEATTLE--Mailing yearly stool kits--an alternative to the often-dreaded colonoscopy--has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from ...

Did you receive a Cologuard test at your door, despite not ordering one? Someone may have ordered it for you.

MILLIONS more people are benefiting from life-saving bowel screening compared to a decade ago – according to the NHS. Almost ...

A stool test is a diagnostic procedure that involves analyzing fecal matter, or poop, to check for signs of infection, inflammation, or disease. The specific analysis depends on a person’s symptoms ...

The kit, known as the faecal immunochemical test (FIT), checks for blood in a small stool sample, which can be a sign of bowel cancer. FIT kits are used at home by putting a poo sample in a small tube ...

In average-risk individuals, ColoSense demonstrated 93% sensitivity for detecting colorectal cancer (CRC) and 45% sensitivity for detecting advanced adenomas (AA). The CRC-PREVENT study evaluated more ...